|
|
Prepublished online as a Blood First Edition Paper on April 24, 2003; DOI 10.1182/blood-2002-11-3349.
Previous Article | Table of Contents | Next Article 
Blood, 15 August 2003, Vol. 102, No. 4, pp. 1534-1540
TRANSPLANTATION
Interleukin-7 improves T-cell recovery after experimental T-celldepleted bone marrow transplantation in T-celldeficient mice by strong expansion of recent thymic emigrants
Annoek E. C. Broers,
Sandra J. Posthumus-van Sluijs,
Hergen Spits,
Bronno van der Holt,
Bob Löwenberg,
Eric Braakman, and
Jan J. Cornelissen
From the Department of Hematology, Erasmus MC/Daniel den Hoed Cancer Center, Rotterdam, the Netherlands; Department of Immunology, Dutch Cancer Institute, Amsterdam, the Netherlands; and Department of Statistics, Erasmus MC/Daniel den Hoed Cancer Center, Rotterdam, the Netherlands.
Interleukin-7 (IL-7) has been shown to enhance thymic output of newly developed T cells following bone marrow transplantation (BMT) in mice. In addition, IL-7 may affect peripheral expansion of T cells. In order to study the relative contribution of thymopoiesis versus peripheral T-cell expansion in the setting of compromised thymopoiesis, we have applied IL-7 in an experimental stem cell transplantation model using T celldeficient RAG-1/ mice. C57BL/6 RAG-1/ mice received transplants of syngeneic T-celldepleted (TCD) bone marrow (Ly5.1) with or without supplemented T cells (Ly5.2). IL-7 was administered until day 63 after BMT. Peripheral blood T- and B-cell recovery was quantified by flow cytometry and thymopoiesis was studied by quantification of T-cell receptor rearrangement excision circles (TRECs). In mice receiving a T-cellreplete BMT, IL-7 selectively expanded mature CD45.2+ T cells without affecting the recovery of new bone marrowderived CD45.1+ T cells. In contrast, IL-7 significantly enhanced the recovery of bone marrowderived T cells after TCD BMT. Quantification of TRECs in mice receiving a TCD BMT revealed that enhanced T-cell recovery following IL-7 treatment resulted from a strong expansion of newly developed naive T cells. These results suggest that peripheral expansion of recent thymic emigrants or mature T cells may be a preferential mechanism by which IL-7 enhances T-cell recovery after BMT.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Sportes, F. T. Hakim, S. A. Memon, H. Zhang, K. S. Chua, M. R. Brown, T. A. Fleisher, M. C. Krumlauf, R. R. Babb, C. K. Chow, et al.
Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets
J. Exp. Med.,
July 7, 2008;
205(7):
1701 - 1714.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Sutherland, L. Spyroglou, J. L. Muirhead, T. S. Heng, A. Prieto-Hinojosa, H. M. Prince, A. P. Chidgey, A. P. Schwarer, and R. L. Boyd
Enhanced Immune System Regeneration in Humans Following Allogeneic or Autologous Hemopoietic Stem Cell Transplantation by Temporary Sex Steroid Blockade
Clin. Cancer Res.,
February 15, 2008;
14(4):
1138 - 1149.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E.C. Broers, M. Bruinsma, S. J. Posthumus-van Sluijs, E.-J. Wils, H. Spits, B. Lowenberg, E. Braakman, and J. J. Cornelissen
IL-7 mediated protection against minor antigen-mismatched allograft rejection is associated with enhanced recovery of regulatory T cells
Haematologica,
August 1, 2007;
92(8):
1099 - 1106.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Andujar, C. Lecomte, A. Renier, J. Fleury-Feith, L. Kheuang, J. Daubriac, A. Janin, and M.-C. Jaurand
Clinico-pathological features and somatic gene alterations in refractory ceramic fibre-induced murine mesothelioma reveal mineral fibre-induced mesothelioma identities
Carcinogenesis,
July 1, 2007;
28(7):
1599 - 1605.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E.-J. Wils, E. Braakman, G. M. G. M. Verjans, E. J. C. Rombouts, A. E. C. Broers, H. G. M. Niesters, G. Wagemaker, F. J. T. Staal, B. Lowenberg, H. Spits, et al.
Flt3 Ligand Expands Lymphoid Progenitors Prior to Recovery of Thymopoiesis and Accelerates T Cell Reconstitution after Bone Marrow Transplantation
J. Immunol.,
March 15, 2007;
178(6):
3551 - 3557.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Swainson, E. Verhoeyen, F.-L. Cosset, and N. Taylor
IL-7R{alpha} Gene Expression Is Inversely Correlated with Cell Cycle Progression in IL-7-Stimulated T Lymphocytes.
J. Immunol.,
June 1, 2006;
176(11):
6702 - 6708.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Samira, C. Ferrand, A. Peled, A. Nagler, Y. Tovbin, H. Ben-Hur, N. Taylor, A. Globerson, and T. Lapidot
Tumor Necrosis Factor Promotes Human T-Cell Development in Nonobese Diabetic/Severe Combined Immunodeficient Mice
Stem Cells,
November 1, 2004;
22(6):
1085 - 1100.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-W. Chu, S. A. Memon, S. O. Sharrow, F. T. Hakim, M. Eckhaus, P. J. Lucas, and R. E. Gress
Exogenous IL-7 increases recent thymic emigrants in peripheral lymphoid tissue without enhanced thymic function
Blood,
August 15, 2004;
104(4):
1110 - 1119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Krenger, H. Schmidlin, G. Cavadini, and G. A. Hollander
On the Relevance of TCR Rearrangement Circles as Molecular Markers for Thymic Output during Experimental Graft-versus-Host Disease
J. Immunol.,
June 15, 2004;
172(12):
7359 - 7367.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|